Treatment of Primary CNS Lymphoma ( FTD )

NCT05274139 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Primary CNS Lymphoma (PCNSL)

Interventions

DRUG: HD-MTX-Ara-C regimen
DRUG: FTD regimen

Sponsor

Mingzhi Zhang

Collaborators

[object Object]